Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Docetaxel vs Docetaxel-Cisplatin in Stage IB-II NSCLC
NCT00132639Phase 2Completed
- Start
- Oct 2002
- Primary completion
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in non-small cell lung cancer (NSCLC) comparing Docetaxel + Cisplatin with Docetaxel (2 arms). Primary endpoint: Disease-Free Survival Rate at 1 Year. Started Oct 2002; status: completed.
02
Drugs
docetaxelcisplatin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00132639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00132639.